Asapiprant is a potent and selective DP1 receptor antagonist, with a Ki of 0.44 nM. Asapiprant exhibited high affinity and selectivity for the DP1 receptor. Treatment with Asapiprant in rats at 10mg/kg significantly (P<0.05) reduces airway hyper-responsiveness (AHR), infiltration of inflammatory cells, and mucin production in bronchoalveolar lavage fluid (BALF), although treatment with Asapiprant at 0.1 mg/kg does not have a significant effect on any responses. In addition, treatment with asapiprant suppressed antigen-induced asthmatic responses, airway hyper-responsiveness, and cell infiltration and mucin production in lung. These results show that asapiprant is a potent and selective DP1 receptor antagonist, and exerts suppressive effects in the animal models of allergic diseases.
Asapiprant, Bulk in stock, contact us by email for Bulk quotation.
For research use only. We do not sell to patients.
Name | Asapiprant |
---|---|
Iupac Chemical Name | 2-(5-(4-((4-Isopropoxyphenyl)sulfonyl)piperazin-1-yl)-2-(oxazol-2-yl)phenoxy)acetic acid |
Synonyms | Asapiprant,S-555739; S 555739; S555739 |
Molecular Formula | C24H27N3O7S |
Molecular Weight | 501.55 |
Smile | C(C)(C)OC1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C=1C=CC(=C(OCC(=O)O)C1)C=1OC=CN1 |
InChiKey | ZMZNWNTZRWXTJU-UHFFFAOYSA-N |
InChi | InChI=1S/C24H27N3O7S/c1-17(2)34-19-4-6-20(7-5-19)35(30,31)27-12-10-26(11-13-27)18-3-8-21(24-25-9-14-32-24)22(15-18)33-16-23(28)29/h3-9,14-15,17H,10-13,16H2,1-2H3,(H,28,29) |
CAS Number | 932372-01-5 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid to white solid |
---|---|
Purity | 98% Min. |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO, not in water |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |
Effect of the potent and selective DP1 receptor antagonist, asapiprant (S-555739), in animal models of allergic rhinitis and allergic asthma.
Takahashi G, et al. Eur J Pharmacol. 2015 Oct 15;765:15-23. PMID: 26277322.